| For: | Zhao YH, Leng SS, Wang Y, Kui FZ, Gan W. Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(11): 110080 [PMID: 41368115 DOI: 10.4254/wjh.v17.i11.110080] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i11/110080.htm |
| Number | Citing Articles |
| 1 |
Molecular Biomarkers Associated with Inflammatory and Fibrotic Pathways in Chronic Liver Disease: A Systematic Review. Al-Najam Journal of Medical and Life Sciences 2026; 1(3) doi: 10.68041/anjmls.v1i3/08
|
| 2 |
Monica Potra, Simona Popescu, Bogdan Timar, Sandra Lazar, Laura Gaita, Adina Braha, Teodora Sorescu, Laura Diaconu, Liana Iordan, Andreea Papoi, Adriana Ivanescu, Romulus Timar. Determinants of Metabolic Dysfunction-Associated Steatotic Liver Diseases in Patients with Type 2 Diabetes Mellitus. Journal of Clinical Medicine 2026; 15(16) doi: 10.3390/jcm15166421
|
| 3 |
Hailin Wang, Qinqin Tang, Juan Hu, Jingdong Li, Qiushi Huang. Exposure-shaped immunometabolic networks in chronic liver disease: translating multi-omics and artificial intelligence into preventive biomarkers. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1866951
|
| 4 |
Damian Świerczek, Maja Dreger, Jakub Jatkowski, Jakub Kancerek, Bogna Drozdzowska, Romuald Wojnicz. From Molecular Mechanisms to Clinical Strategies: A Comprehensive Overview of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences 2026; 27(17) doi: 10.3390/ijms27177825
|